Managed Healthcare Executive February 12, 2025
The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the biosimilars industry.
As part of Managed Healthcare Executive’s coverage of biosimilars and managed care in 2025, we will be reaching out to leaders in the biosimilar industry and in managed care about biosimilars, their pricing and marketing dynamics and how government rules and regulations will affect the biosimilar market. We will also be interviewing outside experts and analysts. Managing Editor Peter Wehrwein spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council and senior vice president of policy and strategic alliances for the Association for Accessible Medicines. The Biosimilars Council is part of the association,...
Today's Sponsors
Today's Sponsor